Fredric L. Coe to Uric Acid
This is a "connection" page, showing publications Fredric L. Coe has written about Uric Acid.
Connection Strength
1.914
-
Proportional reduction of urine supersaturation during nephrolithiasis treatment. J Urol. 2001 Oct; 166(4):1247-51.
Score: 0.196
-
Discrepancy Between Stone and Tissue Mineral Type in Patients with Idiopathic Uric Acid Stones. J Endourol. 2020 03; 34(3):385-393.
Score: 0.175
-
Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia. Kidney Int. 1999 Nov; 56(5):1879-85.
Score: 0.172
-
Divergence between stone composition and urine supersaturation: clinical and laboratory implications. J Urol. 1999 Apr; 161(4):1077-81.
Score: 0.165
-
Evidence for durable kidney stone prevention over several decades. BJU Int. 2009 May; 103(9):1238-46.
Score: 0.081
-
Nephrolithiasis. Prim Care. 2008 Jun; 35(2):369-91, vii.
Score: 0.078
-
Uric acid and calcium oxalate nephrolithiasis. Kidney Int. 1983 Sep; 24(3):392-403.
Score: 0.056
-
Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int. 2003 Jan; 63(1):255-65.
Score: 0.054
-
Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis. Kidney Int. 1982 Oct; 22(4):366-70.
Score: 0.053
-
Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients. J Urol. 2002 Jun; 167(6):2372-6.
Score: 0.051
-
Reduced crystallization inhibition by urine from women with nephrolithiasis. Kidney Int. 2002 May; 61(5):1821-9.
Score: 0.051
-
Differences in urine volume and supersaturation in 2 physician networks. J Urol. 2001 Aug; 166(2):423-8.
Score: 0.049
-
Hyperuricosuria and calcium nephrolithiasis. Urol Clin North Am. 1981 Jun; 8(2):227-44.
Score: 0.048
-
Uric acid saturation in calcium nephrolithiasis. Kidney Int. 1980 May; 17(5):662-8.
Score: 0.045
-
In Vivo Renal Tubule pH in Stone-Forming Human Kidneys. J Endourol. 2020 02; 34(2):203-208.
Score: 0.044
-
Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease. Scand J Urol Nephrol Suppl. 1980; 53:171-7.
Score: 0.044
-
Hyperuricosuric calcium oxalate nephrolithiasis. Adv Exp Med Biol. 1980; 128:439-50.
Score: 0.044
-
Calcium-uric acid nephrolithiasis. Arch Intern Med. 1978 Jul; 138(7):1090-3.
Score: 0.039
-
Supersaturation and stone composition in a network of dispersed treatment sites. J Urol. 1998 Jun; 159(6):1821-5.
Score: 0.039
-
Evidence for a role of PDZ domain-containing proteins to mediate hypophosphatemia in calcium stone formers. Nephrol Dial Transplant. 2018 05 01; 33(5):759-770.
Score: 0.039
-
Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int. 1978 May; 13(5):418-26.
Score: 0.039
-
Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann Intern Med. 1977 Oct; 87(4):404-10.
Score: 0.037
-
Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int. 1997 Mar; 51(3):894-900.
Score: 0.036
-
The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers. J Chronic Dis. 1976 Dec; 29(12):793-800.
Score: 0.035
-
Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc Soc Exp Biol Med. 1975 Sep; 149(4):926-9.
Score: 0.032
-
Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med. 1974 Dec 19; 291(25):1344-50.
Score: 0.031
-
Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis. Acta Urol Belg. 1994 Jun; 62(2):25-9.
Score: 0.030
-
Allopurinol treatment of uric-acid disorders in calcium-stone formers. Lancet. 1973 Jan 20; 1(7795):129-31.
Score: 0.027
-
Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int. 2009 Nov; 76(10):1081-8.
Score: 0.021
-
A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int. 1986 Jul; 30(1):85-90.
Score: 0.017
-
Urine citrate and calcium in calcium nephrolithiasis. Adv Exp Med Biol. 1986; 208:445-9.
Score: 0.016
-
Prevention of kidney stones. Am J Med. 1981 Oct; 71(4):514-6.
Score: 0.012
-
Acclerated calcium nephrolithiasis. JAMA. 1980 Aug 22-29; 244(8):809-10.
Score: 0.011
-
The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers. Scand J Urol Nephrol Suppl. 1980; 53:265-71.
Score: 0.011
-
Treatment of renal calculi. Adv Intern Med. 1980; 26:373-92.
Score: 0.011
-
The natural history of calcium urolithiasis. JAMA. 1977 Oct 03; 238(14):1519-23.
Score: 0.009
-
The performance of a computer system for metabolic assessment of patients with nephrolithiasis. Comput Biomed Res. 1974 Feb; 7(1):40-55.
Score: 0.007
-
Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients. Arch Intern Med. 1982 Mar; 142(3):504-7.
Score: 0.003
-
Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Am J Med. 1982 Jan; 72(1):17-24.
Score: 0.003
-
Idiopathic hypercalciuria in children: prevalence and metabolic characteristics. J Pediatr. 1978 Jun; 92(6):906-10.
Score: 0.002
-
Diseases associated with calcium pyrophosphate dihydrate crystal deposition. Am J Med. 1974 May; 56(5):704-14.
Score: 0.002